|
French target trial using obs data of HCQ vs not in SARS-CoV-2 infection
|
|
5
|
3319
|
June 7, 2026
|
|
Relaxing Assumptions and Targeted Estimands with MOST
|
|
12
|
220
|
May 27, 2026
|
|
A Longitudinal Renal Health Outcome for Clinical Trials in Acute Kidney Injury?
|
|
15
|
173
|
May 22, 2026
|
|
The growing interest in integrating causal inference and Design Theory
|
|
13
|
541
|
May 16, 2026
|
|
Best model reduction approach for Fine-Gray prediction model
|
|
5
|
101
|
March 27, 2026
|
|
Scoping review + SOCI: to assess DHIS2 applicability for NCD
|
|
2
|
74
|
March 26, 2026
|
|
FDA Draft Guidance: Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products
|
|
10
|
947
|
March 2, 2026
|
|
One-sided significance threshold of less than 0.1 in Phase 2 clinical trial
|
|
7
|
145
|
February 25, 2026
|
|
Statin-related side effects: the recent Lancet publication is biased toward false-negatives
|
|
19
|
533
|
February 19, 2026
|
|
Bootstrapped variable selection in the presence of competing risk
|
|
7
|
147
|
January 12, 2026
|
|
Should causal modeling be a required part of a NIH grant applications?
|
|
1
|
123
|
December 17, 2025
|
|
Randomized non-comparative trials: an oxymoron?
|
|
73
|
4599
|
December 15, 2025
|
|
Cause-Agnostic RCT (CAR)
|
|
9
|
494
|
December 12, 2025
|
|
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders – Results from the 2 NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model
|
|
2
|
108
|
December 11, 2025
|
|
MICE Imputation Models
|
|
10
|
457
|
December 6, 2025
|
|
NEJM Trial - proportional hazard assumption
|
|
12
|
434
|
December 1, 2025
|
|
The Design Theory /Causal Inference Divide Explained by the Position of U
|
|
2
|
162
|
November 28, 2025
|
|
Rarity Roulette: A simulator for estimating hypothetical outcomes spreads for mass screenings
|
|
2
|
104
|
November 20, 2025
|
|
Individual response
|
|
266
|
49308
|
November 17, 2025
|
|
When and why (not) to worry about the PO assumption
|
|
4
|
708
|
October 9, 2025
|
|
Comparing multiple groups to a reference group
|
|
7
|
242
|
October 6, 2025
|
|
Bayesian Clinical Trials: Interview with Frank Harrell
|
|
0
|
249
|
September 18, 2025
|
|
Estimating the probability of neonatal sepsis with plug-in incidence
|
|
6
|
152
|
September 11, 2025
|
|
Fine-Gray vs Cause-Specific Cox Regression
|
|
0
|
184
|
September 11, 2025
|
|
Sample Size Calculation for a 2x2 Factorial RCT
|
|
6
|
430
|
September 3, 2025
|
|
Table 2 Fallacy?: Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
|
|
32
|
4296
|
August 12, 2025
|
|
Illogic of Weighting While Estimating Model Parameters
|
|
13
|
832
|
August 11, 2025
|
|
Statistical Process Control and Experimental Design
|
|
9
|
462
|
May 13, 2025
|
|
Challenges in determining meaningful between group differences of surgery vs non-surgical treatment
|
|
12
|
824
|
May 9, 2025
|
|
Why the Non-Reproducibility of Acute Care RCT? The CAP studies
|
|
6
|
219
|
May 8, 2025
|